Intrahepatic chemotherapy in cancer treatment


This route of administration is indicated in patients with colorectal metastasis towards the liver. Intrahepatic chemotherapy is run in one of two ways: via a port catheter placed in the common hepatic artery, using the port body subcutaneously placed below the rib cage, or having a pump surgically implanted right into a subcutaneous pocket in the abdominal wall.

To manage chemotherapy with an arterial port catheter, a noncoring needle can be used to gain access to the unit. To manage chemotherapy via a pump, a unique noncoring pump needle can be used percutaneously to gain access to the pump's flat, circular septum, that is attached to a drug reservoir.

Hepatic pump models range from the Medtronic, the Arrow, and also the Infusaid pumps. By way of percutaneous injection, the pump reservoir is stuffed with a real estate agent that is infused in the pump right into a vein, an artery, or perhaps a body cavity. The charging fluid in a little inner chamber is recharged intrinsically each time the pump is re-filled.

If not being accustomed to administer chemotherapy, this pump should be refilled every 2 weeks by having an infusate means to fix ensure that it remains charged and ready to be used.

The rest of the infusate should be withdrawn in the pump before more infusate could be administered and before the agent could be administered in to the reservoir. The pump should be manipulated only by qualified personnel, who should stick to the manufacturer's instructions regarding proper use.

Flow rates vary from 1 to 2 mL/day and therefore are predetermined by the manufacturer. Flow rates increase at high altitudes, with fever, with hypertension. Ambulatory hepatic infusion pumps may cause chemical hepatitis, chemical cholecystitis, and cholangitis.

Legal Disclaimer

Our website is not responsible for the information contained by this article. Webworldarticles.com is a free articles resource thus practically any visitor can submit an article. However if you notice any copyrighted material, please contact us and we will remove the article(s) in discussion right away.


This article was sent to us by: Duane Owens at 07262011

Related Articles

1. Chemotherapy and how it affects cells
The cell cycle may be the cornerstone of cell division and proliferation. Both normal and malignant cells undergo this method, which might are approximately 25 to 30 hours....

2. Short classification of some chemotherapeutic agents
Antineoplastic medicine is classified based on the mode of action and also the phase of the cell cycle in that the drug is active. This classification isn't absolute; chanc...

3. Alkylating agents used in chemotherapy to fight cancer cells
Alkylating agents Alkylating agents alter DNA structure with the poorly understood procedure for alkylation, which ends in cross-linking and strand breaking of DN...

4. Chemotherapy and Biologic Response Modifiers in cancer treatment
Biologic treatments are your fourth modality in the treatment of cancer, after surgery, chemotherapy, and radiation. Biologic therapy produces anticancer effects through ei...

5. Immunotoxin therapy and chemotherapy in cancer treatment
Immunotoxin therapy continues to be designed to deliver toxins towards the tumor cell to result in cell death. Toxins used are incredibly potent bacterial or plant products...

6. Hematopoietic growth factors and chemotherapy in cancer treatment
Hematopoietic growth factors are naturally sourced hormone-like glycoproteins that regulate the proliferation, differentiation, and maturation of blood cells by binding to ...

7. Vaccine and gene therapy in various malignancies
Vaccine therapy Vaccine therapy continues to be studied in various malignancies for example breast, melanoma, colon, and lung cancers. The introduction of tumor v...

8. Chemotherapy progress and drug development in cancer treatment
Based on federal regulations governing the security of human subjects, scientific studies are "the systematic investigation, including research development, testing, and ev...